CAMBRIDGE, MA—Add Eli Lilly and Co. to theimpressive list of biopharmaceutical and life science companiesthat do business in the Boston area.

The Indianapolis-based firm reports that it will establishThe Lilly Cambridge Innovation Center inapproximately 17,000 square feet of space at 450 Kendall St. inKendall Square in Cambridge. Building owner BioMed RealtyTrust, Inc. of San Diego, CA reports that Eli Lilly hassigned a 10-year lease for 16,798 square feet of laboratory andoffice space on the third floor of the 63,000-square-foot building.The lease marks the company's entrance into the state ofMassachusetts. Eli Lilly employs approximately 41,000 workersworldwide, including more than 8,000 in the field of research anddevelopment.

Eli Lilly reports that construction is expected to beginimmediately on its new space with expected occupancy of its newfacility by the end of this year. The firm is in control of themulti-million dollar build out of its space on the third floor ofthe building. Transwestern |RBJ represented BioMed Realty Trust in the leasetransaction. MPM Capital is also a tenant at the building,occupying space on the fifth floor, according to a spokesman forBioMed Realty Trust.

Want to continue reading?
Become a Free ALM Digital Reader.

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

John Jordan

John Jordan is a veteran journalist with 36 years of print and digital media experience.